Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Chugai Pharmaceutical Co ( (JP:4519) ) has issued an update.
Chugai Pharmaceutical announced a significant increase in dividends per share for the fiscal year ending December 31, 2024, driven by an eighth consecutive year of increased Core net income and a 19.0% rise in Core EPS. Looking forward, the company plans substantial dividends for 2025, including special dividends to commemorate its 100th anniversary, projecting a total of ¥250 per share and a Core dividend payout ratio of 100.0%, highlighting its commitment to stable profit allocation for shareholders.
More about Chugai Pharmaceutical Co
Chugai Pharmaceutical Co., Ltd. is a leading player in the pharmaceutical industry, focusing on the development and distribution of innovative medical solutions. The company is listed on the Prime Market of the Tokyo Stock Exchange and is headquartered in Tokyo, Japan.
YTD Price Performance: -7.82%
Average Trading Volume: 7,366
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $67.98B
For an in-depth examination of 4519 stock, go to TipRanks’ Stock Analysis page.
